| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Klacid 250 mg - T | 14 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G |  |
| | | IP | CI | | Klacid 250 mg - T | 20 Tablet(s) | 14.65 | 32.20 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| L | | IP | CI | | Klacid 250 mg - T | 70 Tablet(s) | 46.51 | 67.00 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 500 mg - T | 14 Tablet(s) | 16.65 | 34.45 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Viatris Pharma GmbH | ● A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 500 mg - T | 20 Tablet(s) | 25.60 | 44.10 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Viatris Pharma GmbH | ● A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 500 mg - T | 30 Tablet(s) | 35.61 | 54.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Viatris Pharma GmbH | ● A / SL / SO | FB | | G | |
| | | IP | CI | | Klaciped | 100 ml | 6.00 | 15.75 | 10 % | | Kindersuspension: Clarithromycinum 125 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Klaciped Forte | 100 ml | 10.90 | 28.20 | 10 % | | Kindersuspension: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 250 - T | 14 Tablet(s) | 10.01 | 27.25 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 250 - T | 20 Tablet(s) | 12.47 | 29.95 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 14 Tablet(s) | 15.18 | 32.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 20 Tablet(s) | 23.88 | 42.35 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 250 mg | 14 | 9.30 | 26.55 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 250 mg | 20 | 12.39 | 29.90 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 14 | 15.18 | 32.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 20 | 23.13 | 41.55 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 14 | 9.29 | 26.55 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 20 | 12.38 | 29.90 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 14 | 15.18 | 32.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 20 | 21.66 | 40.05 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 30 | 32.13 | 51.35 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 125 | 100 ml | 5.93 | 15.70 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 125 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC
forte 250 | 100 ml | 9.98 | 27.25 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 250 mg | Spirig HealthCare AG | ● A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 125 | 100 ml | 5.48 | 15.20 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 125 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 100 ml | 9.98 | 27.25 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| L | | IP | | | Klacid i.v. | ampoule(s) | 17.70 | 35.65 | 10 % | | Infusion preparation: Clarithromycinum 500 mg | Viatris Pharma GmbH | A / SL | FB | | G | |
| | | IP | | | Clarithromycine Labatec 500 mg
i.v. | 500 mg | PR | PR | k.A. | | Dry substance: Clarithromycinum 500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 250 - T | 70 Tablet(s) | PR | PR | k.A. | | Coated tablets: Clarithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 30 Tablet(s) | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 120 Tablet(s) | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 250 mg | 70 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 250 mg | Spirig HealthCare AG | A | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 30 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 120 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 70 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 250 mg | Mepha Pharma AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 120 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A | FB | | G | |
